IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q4 2020 Holdings

Filed 2021-02-16 | 60 holdings | $851.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Avantor Inc(AVTR)ACOM05352A100$25.9M920,6503.0%
Teva Pharmaceutical Inds LTD(TEVA)ASPONSORED ADS881624209$26.5M2,748,2503.1%
Danaher Corporation(DHR)ACOM235851102$28.1M126,3303.3%
Envista Holdings Corporation(NVST)ACOM29415F104$29.1M861,3553.4%
Catalent Inc(CTLTEUR)ACOM148806102$29.1M279,5033.4%
Ascendis Pharma A/S(ASND)ASPONSORED ADR04351P101$31.2M187,0433.7%
Glaxosmithkline PLCASPONSORED ADR37733W105$35.2M946,5814.1%
Fate Therapeutics Inc(FATE)ACOM31189P102$36.3M399,4994.3%
Horizon Therapeutics PUB LASHSG46188101$38.8M530,9764.6%
Astrazeneca PLC(AZN)ASPONSORED ADR046353108$42.6M852,4315.0%
TG Therapeutics Inc(TGTX)ACOM88322Q108$44.9M863,8515.3%
Alexion Pharmaceuticals Inc(ALXN)ACOM015351109$58.8M376,2006.9%
United Therapeutics Corp del(UTHR)ACOM91307C102$69.6M458,6368.2%
Amarin Corp PLCASPONS ADR NEW023111206$78.0M15,943,9159.2%
PreviousPage 2 of 2